Bromopride
CAS: 4093-35-0
Rif. 3D-FB19308
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione | ||
100mg | Fuori produzione |
Informazioni sul prodotto
- 4-Amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide2-Methoxy-4-amino-5-bromo-N,N-diethylaminoethylbenzamideN-Diethylamino ethyl-2-methoxy-4-amino-5-bromobenzamide
- 2-Methoxy-4-amino-5-bromo-N,N-diethylaminoethylbenzamide
- 4-Amino-5-bromo-N-(2-(diethylamino)ethyl)-o-anisamide
- 4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
- Artomey
- Benzamide, 4-amino-5-bromo-N-(2-(diethylamino)ethyl)-2-methoxy- (9CI)
- Benzamide, 4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxy-
- Brn 2381893
- Bromoprida
- Bromoprida [INN-Spanish]
- Vedi altri sinonimi
- Bromoprida [Spanish]
- Bromopride [INN:DCF]
- Bromopridum
- Bromopridum [INN-Latin]
- Emepride
- Emoril
- N-(Diethylaminoethyl)-2-methoxy-4-amino-5-bromobenzamide
- Unii-75473V2Yzk
- Val 13081
- Valopride
- Viadil
- o-Anisamide, 4-amino-5-bromo-N-(2-(diethylamino)ethyl)-
- Bromopride
Bromopride is a drug that belongs to the group of antirheumatic drugs, which are used for the treatment of symptoms such as pain, swelling, and stiffness in joints. Bromopride inhibits the cb2 receptor and the adenosine receptor antagonist. It also has an intramolecular hydrogen bond with the dopamine molecule. This drug has been shown to be effective against vasoactive intestinal peptide-induced rat paw edema. Bromopride is not active against dopamine-induced rat paw edema or tnf-α-induced rat paw edema.